The choice of antihypertensive agents for patients with stroke or cognitive impairment. Implication in brain renin angiotensin system

DOI 18 References
  • Mogi Masaki
    Department of Molecular Cardiovascular Biology and Pharmacology Ehime University, Graduate School of Medicine
  • Horiuchi Masatsugu
    Department of Molecular Cardiovascular Biology and Pharmacology Ehime University, Graduate School of Medicine

Bibliographic Information

Other Title
  • 基礎実験から見た脳卒中・認知機能低下への降圧療法の選択　　脳内レニン・アンジオテンシン系の役割

Search this article

Description

Blockade of renin angiotensin system (RAS) is effective to prevent onset of stroke. However, the detailed mechanism is still an enigma. Here we discuss about the role of RAS in brain damage after stroke and cognitive decline associated with metabolic syndrome. Increase in angiotensin II in the brain enhanced ischemic damage after middle cerebral artery occlusion. On the other hand, temporal blockade of RAS even after cessation of angiotensin II type-1 receptor blocker (ARB) treatment prevented brain damage with increase capillary density in the brain. Angiotensin II type-2 (AT2) receptor signaling contributes to protect brain via enhancement of neural differentiation. Moreover, AT2 receptor signaling in the other tissue also contributes to brain protection. For example, bone marrow stromal cells (MSCs) have been expected to improve the brain damage by transplantation after stroke; however, MSCs prepared from AT2 receptor deficient mice could not improve survival rate in mice after ischemia-reperfusion injury. Finally, cognitive impairment observed in type 2 diabetic model mice and mice fed with metabolic syndrome prone diet was prevented by treatment with nonhypotensive dose of ARBs. These results suggest that regulation of RAS by ARB could be a therapeutical benefit to prevent brain damage in patients with hypertension.<br>

Journal

References(18)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top